Health industry - cancer detection technology Market Cap $82m Sufficient cash for 2 years at current spend No news for months has caused the SP to slide Current SP 7.7c QUARTERLY DUE THIS WEEK
IBX is slow on news however if positive news arrives in the Quarterly this week regarding trial progress it should have a markedly positive effect on the SP again, hopefully returning it to its FY21 high of 21c.
Could be a quick trade if news is good. If not, get out fast or be ready to hold for another quarter.
Riesling _________________
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to find and detect cancer.
